Literature DB >> 16275894

Virulent clinical isolates of Mycobacterium tuberculosis grow rapidly and induce cellular necrosis but minimal apoptosis in murine macrophages.

Jae Seuk Park1, Marcela Henao Tamayo, Mercedes Gonzalez-Juarrero, Ian M Orme, Diane J Ordway.   

Abstract

In this study, we investigated the ability of four clinical isolates of Mycobacterium tuberculosis representing a range of virulence for their capacity to grow in bone marrow-derived macrophages. The rate of growth of each of the isolates in macrophages reflected their known virulence, but the most virulent isolates strongly induced production of the cytokine tumor necrosis factor alpha. A key difference, however, was the degree of cell cytotoxicity observed with the more virulent strains after several days in culture. Staining of cell monolayers for DNA fragmentation indicative of apoptosis showed that this was minimal and only evident to any degree in macrophages infected with the most virulent strains. In contrast, electron microscopy revealed damage of macrophages consistent with cell necrosis. These results suggest that rapid intracellular growth rate and induction of necrotic cell death within host macrophages are virulence factors of M. tuberculosis in the early stages of bacterial infection. They further imply that infected cell apoptosis, regarded as a defense mechanism or cross-priming mechanism, plays a minimal role.

Entities:  

Mesh:

Year:  2005        PMID: 16275894     DOI: 10.1189/jlb.0505250

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  62 in total

1.  Does M. tuberculosis genomic diversity explain disease diversity?

Authors:  Mireilla Coscolla; Sebastien Gagneux
Journal:  Drug Discov Today Dis Mech       Date:  2010

2.  Polyphosphate is an extracellular signal that can facilitate bacterial survival in eukaryotic cells.

Authors:  Ramesh Rijal; Louis A Cadena; Morgan R Smith; Joseph F Carr; Richard H Gomer
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-02       Impact factor: 11.205

Review 3.  Development of new vaccines and drugs for TB: limitations and potential strategic errors.

Authors:  Ian M Orme
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

Review 4.  Cell death and autophagy in tuberculosis.

Authors:  Andrew H Moraco; Hardy Kornfeld
Journal:  Semin Immunol       Date:  2014-10-17       Impact factor: 11.130

Review 5.  Autophagy in Pulmonary Innate Immunity.

Authors:  Lang Rao; N Tony Eissa
Journal:  J Innate Immun       Date:  2019-04-24       Impact factor: 7.349

6.  Anti-apoptotic genes in the survival of monocytic cells during infection.

Authors:  Aurelia Busca; Mansi Saxena; Marko Kryworuchko; Ashok Kumar
Journal:  Curr Genomics       Date:  2009-08       Impact factor: 2.236

7.  Secreted Mycobacterium tuberculosis Rv3654c and Rv3655c proteins participate in the suppression of macrophage apoptosis.

Authors:  Lia Danelishvili; Yoshitaka Yamazaki; Jeannie Selker; Luiz E Bermudez
Journal:  PLoS One       Date:  2010-05-04       Impact factor: 3.240

8.  Interferon-γ Regulates the Death of M. tuberculosis-Infected Macrophages.

Authors:  Jinhee Lee; Hardy Kornfeld
Journal:  J Cell Death       Date:  2010-03-03

9.  Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival.

Authors:  Susanne Homolka; Stefan Niemann; David G Russell; Kyle H Rohde
Journal:  PLoS Pathog       Date:  2010-07-08       Impact factor: 6.823

10.  Genetic determination of the effect of post-translational modification on the innate immune response to the 19 kDa lipoprotein of Mycobacterium tuberculosis.

Authors:  Katalin A Wilkinson; Sandra M Newton; Graham R Stewart; Adrian R Martineau; Janisha Patel; Susan M Sullivan; Jean-Louis Herrmann; Olivier Neyrolles; Douglas B Young; Robert J Wilkinson
Journal:  BMC Microbiol       Date:  2009-05-14       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.